CD93 and cancer: In a human pan-cancer analysis of transcriptomic and mutational data from several online databases, CD93 was found to be upregulated in most cancers such as cholangiocarcinoma, ovarian, pancreatic, gastric, melanoma, and kidney but down regulated in lung adenocarcinoma and bladder urothelial cancer [40].